Testing whether inpatient flu shots improve vaccination rates
Part of Infections, Lungs & breathing clinical trials.
This trial looks at an organized plan to give flu vaccines during hospital stays. It may help more inpatients get protected against influenza before they leave the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 6 months old
- You are currently admitted as an inpatient at a participating hospital
- You are not in the hospital’s critical care unit (for example, ICU)
- You are not admitted under the hematology/oncology service (blood cancer or cancer care)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two flu medicines—Tamiflu and Xofluza—to see if they can prevent flu in people who are staying in a hospital room with a patient who has the flu. You may join if you are a hospitalized close contact (roommate or caregiver) and test negative for flu.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This study looks at how your immune system (your body’s infection-fighting system) responds after you get the seasonal flu vaccine. It may help researchers understand what the vaccine triggers in people working in healthcare and labs.
This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.